Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis

Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis

The role of cytoreductive nephrectomy (CN) in the treatment of metastatic renal cell carcinoma (mRCC) remains controversial during the targeted therapy era. To reconcile the current literature, we analyzed the reported survival data at the individual patient level and compared the long-term survival...

Full description

Bibliographic Details
Main Authors: Stepan M. Esagian, Ioannis A. Ziogas, Dimitrios Kosmidis, Mohammad D. Hossain, Nizar M. Tannir, Pavlos Msaouel
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
cytoreductive nephrectomy
renal cell carcinoma
targeted therapy
tyrosine kinase inhibitors
VEGF inhibitors
mammalian target of rapamycin inhibitors
Online Access:https://www.mdpi.com/2072-6694/13/4/695

Internet

https://www.mdpi.com/2072-6694/13/4/695

Similar Items